Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Isradipine enhancement of virtual reality cue exposure for smoking cessation: Rationale and study protocol for a double-blind randomized controlled trial

Contemporary Clinical Trials(2020)10.1016/j.cct.2020.106013Source: DataRank Database

Isradipine enhancement of virtual reality cue exposure for smoking cessation: Rationale and study protocol for a double-blind randomized controlled trial is a research paper published in Contemporary Clinical Trials (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.52)OA: greenTopics (52)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Cara C. Young ORCID,Catherine S. Gebhardt,Alex Perrone,Hitoshi Morikawa ORCID,Michael W. Otto ORCID

Live enrichment

PubMed:32335287 OpenAlex:https://openalex.org/W3018233939

National Institutes of Health

Grant: 1R21DA049539-01

Isradipine and Virtual Reality Cue Exposure for Smoking Cessation

NIDA NIH HHS

Grant: R21 DA049539

FWCI

0.52

Citation Percentile

0.6%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7446235

publisherhttps://api.elsevier.com/content/article/PII:S1551714420300914?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1551714420300914?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cct.2020.106013

Fields of Study

Nicotinic Acetylcholine Receptors StudySmoking Behavior and CessationOlfactory and Sensory Function Studies03 medical and health sciences0302 clinical medicine0305 other medical scienceCuesDelivery of Health CareHumansIsradipineRandomized Controlled Trials as TopicSmoking CessationVirtual Reality

MeSH Terms

Virtual RealityCuesDelivery of Health CareHumansRandomized Controlled Trials as TopicSmoking CessationIsradipine

Keywords

IsradipineMedicineCravingSmoking cessationAbstinencePsychological interventionPlaceboRandomized controlled trialClinical trialProtocol (science)AddictionPsychiatryAlternative medicineInternal medicineVirtual RealitySubstance Abuse and AddictionSocial and Behavioral SciencesPsyArXiv|Social and Behavioral Sciences|Clinical PsychologyPsyArXiv|Social and Behavioral SciencesClinical Psychologybepress|Social and Behavioral Sciences|Psychology|Clinical Psychologybepress|Social and Behavioral SciencesPsyArXiv|Social and Behavioral Sciences|Clinical Psychology|Substance Abuse and AddictionHumansCuesDelivery of Health CareRandomized Controlled Trials as TopicExtinction enhancerImmersive video environmentNicotineSmoking relapseVirtual reality cue exposure

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being